Large-scale, randomised controlled trials specifically designed to assess acne as a primary outcome of B12 supplementation are lacking
GHK-Cu dosage matters because the peptide works through cellular signalling , not brute force
doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
This is one of the most effective synergies in the entire protocol
Each peptide has a different research focus
This is the standard choice for multi-dose peptide vials